Melina Schlag
Essen, NW 45147, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany.
Journal: European journal of neurology
Published: December 15, 2025
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam.
Journal: Journal of neurology
Published: November 03, 2025
Performance fatigability in adults with spinal muscular atrophy treated long-term with nusinersen.
Journal: Muscle & nerve
Published: December 28, 2023
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment.
Journal: Journal of neurology
Published: September 08, 2023
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study.
Journal: Journal of fungi (Basel, Switzerland)
Published: March 05, 2023
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.
Journal: Therapeutic advances in neurological disorders
Published: January 03, 2021
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.
Journal: European journal of neurology
Published: April 24, 2020
Fatigue in adults with spinal muscular atrophy under treatment with nusinersen.
Journal: Scientific reports
Published: February 14, 2020
Neurofilament Heavy Chain and Tau Protein Are Not Elevated in Cerebrospinal Fluid of Adult Patients with Spinal Muscular Atrophy during Loading with Nusinersen.
Journal: International journal of molecular sciences
Published: October 14, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026